Although the data are still somewhat conflicting at this point (Dezentjé et al, 2009), CYP2D6 genotyping might become the first predictive factor in breast cancer patients that may be analysed in a blood sample in the near future. The gene discussed is CYP2D6; the disease is breast carcinoma.